BDBM235335 US10052306, 131::US10052306, 281::rac-(3aR,5r,6aS)-5- benzyl-2-(2-hydroxy-2- (4- hydroxyphenyl)ethyl)octa- hydrocyclopenta[c]pyrrol- 5-ol

SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)cc1

InChI Key InChIKey=PFQYYQCYAUKHMU-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 235335   

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Cadent Therapeutics

US Patent
LigandPNGBDBM235335(rac-(3aR,5r,6aS)-5- benzyl-2-(2-hydroxy-2- (4- hyd...)
Affinity DataIC50: 25.5nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Cadent Therapeutics

US Patent
LigandPNGBDBM235335(rac-(3aR,5r,6aS)-5- benzyl-2-(2-hydroxy-2- (4- hyd...)
Affinity DataIC50: 17.4nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
Go to US Patent